oral bpc 157 dose BPC-157 Benefits, Dosage & Before/After Results BPC 157: Science-Backed Uses, Benefits,

Most patients have reached their primary treatment objectives by this point

There can be no assurance that the securities held by the Fund will stay within the Funds intended market capitalization range

doi: 10.32474/OAJESS.2019.02.000144 68

Disclosure of interest: All authors have nothing to disclose Poster Session I - INTRACRANIAL HEMORRHAGE 02.00 - INTRACRANIAL HEMORRHAGE - 02.01 - INTRACEREBRAL HAEMORRHAGE P153 - ESOC25-601 MIDDLE MENINGEAL ARTERY EMBOLIZATION IN A COHORT OF PATIENTS ON ANTITHROMBOTIC THERAPY Eduardo Fandio 1 , Isabel Bermudez-Coronel 1 , Mara Prez 1 , Jose Carlos Mendez 1 , Rodrigo Carrasco 1 , Vctor Rodrguez 1 , Lara Castellanos 1 , Eva Cortina 1 , Karolina Monsior 1 , Luis Ley 1 1 Hospital Universitario Ramn y Cajal, Madrid, Spain Background and Aims: To evaluate the effectiveness and safety of middle meningeal artery embolization in chronic subdural hematoma patients on antithrombotic therapy